189 related articles for article (PubMed ID: 16098969)
1. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.
Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP
FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969
[TBL] [Abstract][Full Text] [Related]
2. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
3. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
[TBL] [Abstract][Full Text] [Related]
4. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
[TBL] [Abstract][Full Text] [Related]
5. Laminin-6 assembles into multimolecular fibrillar complexes with perlecan and participates in mechanical-signal transduction via a dystroglycan-dependent, integrin-independent mechanism.
Jones JC; Lane K; Hopkinson SB; Lecuona E; Geiger RC; Dean DA; Correa-Meyer E; Gonzales M; Campbell K; Sznajder JI; Budinger S
J Cell Sci; 2005 Jun; 118(Pt 12):2557-66. PubMed ID: 15928048
[TBL] [Abstract][Full Text] [Related]
6. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.
Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822
[TBL] [Abstract][Full Text] [Related]
7. Post-translational maturation of dystroglycan is necessary for pikachurin binding and ribbon synaptic localization.
Kanagawa M; Omori Y; Sato S; Kobayashi K; Miyagoe-Suzuki Y; Takeda S; Endo T; Furukawa T; Toda T
J Biol Chem; 2010 Oct; 285(41):31208-16. PubMed ID: 20682766
[TBL] [Abstract][Full Text] [Related]
8. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
Elife; 2023 Feb; 12():. PubMed ID: 36723429
[TBL] [Abstract][Full Text] [Related]
9. Abnormal glycosylation of dystroglycan in human genetic disease.
Hewitt JE
Biochim Biophys Acta; 2009 Sep; 1792(9):853-61. PubMed ID: 19539754
[TBL] [Abstract][Full Text] [Related]
10. The inside and out of dystroglycan post-translational modification.
Moore CJ; Winder SJ
Neuromuscul Disord; 2012 Nov; 22(11):959-65. PubMed ID: 22770978
[TBL] [Abstract][Full Text] [Related]
11. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
[TBL] [Abstract][Full Text] [Related]
12. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
[TBL] [Abstract][Full Text] [Related]
13. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
[TBL] [Abstract][Full Text] [Related]
14. Dystroglycan glycosylation and muscular dystrophy.
Moore CJ; Hewitt JE
Glycoconj J; 2009 Apr; 26(3):349-57. PubMed ID: 18773291
[TBL] [Abstract][Full Text] [Related]
15. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding.
Zhang Z; Zhang P; Hu H
PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062
[TBL] [Abstract][Full Text] [Related]
16. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse.
Grewal PK; Holzfeind PJ; Bittner RE; Hewitt JE
Nat Genet; 2001 Jun; 28(2):151-4. PubMed ID: 11381262
[TBL] [Abstract][Full Text] [Related]
17. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.
Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP
Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface laminin organization.
Henry MD; Satz JS; Brakebusch C; Costell M; Gustafsson E; Fässler R; Campbell KP
J Cell Sci; 2001 Mar; 114(Pt 6):1137-44. PubMed ID: 11228157
[TBL] [Abstract][Full Text] [Related]
19. Dystroglycan matrix receptor function in cardiac myocytes is important for limiting activity-induced myocardial damage.
Michele DE; Kabaeva Z; Davis SL; Weiss RM; Campbell KP
Circ Res; 2009 Nov; 105(10):984-93. PubMed ID: 19797173
[TBL] [Abstract][Full Text] [Related]
20. [Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders].
Toda T
Rinsho Shinkeigaku; 2009 Nov; 49(11):859-62. PubMed ID: 20030231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
